These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 20599838)
21. Cannabinoids modulate ultrasound-induced aversive responses in rats. Finn DP; Jhaveri MD; Beckett SR; Kendall DA; Marsden CA; Chapman V Psychopharmacology (Berl); 2004 Feb; 172(1):41-51. PubMed ID: 14634713 [TBL] [Abstract][Full Text] [Related]
22. Prolonged cannabinoid treatment results in spatial working memory deficits and impaired long-term potentiation in the CA1 region of the hippocampus in vivo. Hill MN; Froc DJ; Fox CJ; Gorzalka BB; Christie BR Eur J Neurosci; 2004 Aug; 20(3):859-63. PubMed ID: 15255998 [TBL] [Abstract][Full Text] [Related]
23. Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum. Cheer JF; Kendall DA; Mason R; Marsden CA Neuropharmacology; 2003 Apr; 44(5):633-41. PubMed ID: 12668049 [TBL] [Abstract][Full Text] [Related]
24. Cannabinoid receptors and reward in the rat: a conditioned place preference study. Cheer JF; Kendall DA; Marsden CA Psychopharmacology (Berl); 2000 Jul; 151(1):25-30. PubMed ID: 10958113 [TBL] [Abstract][Full Text] [Related]
25. Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat. Elmes SJR; Winyard LA; Medhurst SJ; Clayton NM; Wilson AW; Kendall DA; Chapman V Pain; 2005 Dec; 118(3):327-335. PubMed ID: 16289798 [TBL] [Abstract][Full Text] [Related]
26. Effects of the synthetic cannabinoid nabilone on spatial learning and hippocampal neurotransmission. Diana G; Malloni M; Pieri M Pharmacol Biochem Behav; 2003 Jun; 75(3):585-91. PubMed ID: 12895676 [TBL] [Abstract][Full Text] [Related]
27. Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus. Steindel F; Lerner R; Häring M; Ruehle S; Marsicano G; Lutz B; Monory K J Neurochem; 2013 Mar; 124(6):795-807. PubMed ID: 23289830 [TBL] [Abstract][Full Text] [Related]
28. Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivo. Bosier B; Muccioli GG; Mertens B; Sarre S; Michotte Y; Lambert DM; Hermans E Neuropharmacology; 2012 Jun; 62(7):2328-36. PubMed ID: 22365976 [TBL] [Abstract][Full Text] [Related]
30. Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats. Garcia-Gil L; de Miguel R; Romero J; Perez A; Ramos JA; Fernández-Ruiz JJ Neurotoxicol Teratol; 1999; 21(3):277-83. PubMed ID: 10386831 [TBL] [Abstract][Full Text] [Related]
31. Sex-specific alterations in hippocampal cannabinoid 1 receptor expression following adolescent delta-9-tetrahydrocannabinol treatment in the rat. Silva L; Harte-Hargrove L; Izenwasser S; Frank A; Wade D; Dow-Edwards D Neurosci Lett; 2015 Aug; 602():89-94. PubMed ID: 26118897 [TBL] [Abstract][Full Text] [Related]
32. The action of synthetic cannabinoids on the induction of long-term potentiation in the rat hippocampal slice. Collins DR; Pertwee RG; Davies SN Eur J Pharmacol; 1994 Jul; 259(3):R7-8. PubMed ID: 7982446 [TBL] [Abstract][Full Text] [Related]
33. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852 [TBL] [Abstract][Full Text] [Related]
34. Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. O'Shea M; Singh ME; McGregor IS; Mallet PE J Psychopharmacol; 2004 Dec; 18(4):502-8. PubMed ID: 15582916 [TBL] [Abstract][Full Text] [Related]
35. Effect of synthetic cannabinoid HU210 on memory deficits and neuropathology in Alzheimer's disease mouse model. Chen B; Bromley-Brits K; He G; Cai F; Zhang X; Song W Curr Alzheimer Res; 2010 May; 7(3):255-61. PubMed ID: 20043809 [TBL] [Abstract][Full Text] [Related]
36. Transient oligemia is associated with long-term changes in binding densities of cortical inhibitory GABAA receptors in the rat brain. Frauenknecht K; Plaschke K; Sommer C Brain Res; 2009 May; 1271():95-102. PubMed ID: 19328192 [TBL] [Abstract][Full Text] [Related]
37. Changes of GABA(A) receptor binding and subunit mRNA level in rat brain by infusion of subtoxic dose of MK-801. Kim HS; Choi HS; Lee SY; Oh S Brain Res; 2000 Oct; 880(1-2):28-37. PubMed ID: 11032987 [TBL] [Abstract][Full Text] [Related]
38. Down-regulation of benzodiazepine binding to alpha 5 subunit-containing gamma-aminobutyric Acid(A) receptors in tolerant rat brain indicates particular involvement of the hippocampal CA1 region. Li M; Szabo A; Rosenberg HC J Pharmacol Exp Ther; 2000 Nov; 295(2):689-96. PubMed ID: 11046107 [TBL] [Abstract][Full Text] [Related]